|Bid||5.05 x 27000|
|Ask||5.09 x 4000|
|Day's Range||4.97 - 5.16|
|52 Week Range||4.00 - 10.56|
|Beta (5Y Monthly)||1.78|
|PE Ratio (TTM)||2.60|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
For a long time, Cronos Group (NASDAQ: CRON) was unable to climb higher than third place among Canadian cannabis producers based on market cap. Meanwhile, Canopy Growth (NYSE: CGC) has fairly consistently held onto the top spot except for brief periods. Neither Cronos nor Canopy has made investors happy so far in 2020, however.
Its partnership with tobacco giant Altria is appealing, but keep an eye on these three issues before you pick this pot stock.
John Kagia, New Frontier Data Cheif Knowledge Officer, joins Yahoo Finance's Zach Guzman to discuss the cannabis outlook amid COVID-19 and the 2020 Presidential election.